A point-of-care lateral flow assay for semiquantitative detection of vitamin A deficiency for low-resource settings

Abstract Vitamin A is essential for vision, neurodevelopment, immunity and other functions. Vitamin A deficiency (VAD) remains prevalent in low-resource settings and vulnerable populations, particularly during pregnancy and lactation and in children, due to the unavailability of advanced detection methods. An inexpensive point-of-care semi-quantitative method could support early detection of VAD in such conditions. This study used a gold nanoparticle (AuNP)- based lateral flow assay (LFA) to detect VAD, with retinol-binding protein (RBP) as a Marker. The Nanoparticle Tracking Analysis and NanoDrop were used to characterize AuNPs conjugated with anti-RBP antibody and to determine the optimal conjugation pH, respectively. Antibody concentrations were optimized on nitrocellulose membranes to achieve reproducible, semi-quantitative visual signals. The values obtained from the LFA semiquantitative kit were confirmed and validated by ELISA, and the developed color chart was evaluated for sensitivity, specificity, and accuracy. Optimal conditions for antibody conjugation were achieved at pH 8.5, and 0.5–1 µg of the capture antibody resulted in the formation of the test line. The LFA demonstrated good agreement with ELISA in distinguishing low RBP from normal RBP levels, enabling classification into normal (> 19 µg/mL), subclinical (12–19 µg/mL), and clinical deficiency (< 12 µg/mL) categories, with 93.70% accuracy, 93.95% sensitivity, and 92.73% specificity. The presented semiquantitative LFA demonstrates promising results for a rapid, simple, economical, and point-of-care screening for VAD, suitable for limited-resource settings. While clinical verification is needed to validate the clinical cutoffs and the test’s feasibility for Point-of-care screening, this kit provides an opportunity to develop several semiquantitative kits for other biomarker proteins.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-14
DOI
https://doi.org/10.1038/s41598-026-79841-z
Primary Topic
Biosensors and Analytical Detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A point-of-care lateral flow assay for semiquantitative detection of vitamin A deficiency for low-resource settings

Gayathri M Rao, Kavitha S. Shettigar, Dinesh Upadhya, Srinivas Hebbar et al.
Scientific Reports
Biosensors and Analytical Detection
article

A point-of-care lateral flow assay for semiquantitative detection of vitamin A deficiency for low-resource settings

Gayathri M Rao, Kavitha S. Shettigar, Dinesh Upadhya, Srinivas Hebbar, Lavita Pinto, Harshitha Mahesh
article en

Abstract

Abstract Vitamin A is essential for vision, neurodevelopment, immunity and other functions. Vitamin A deficiency (VAD) remains prevalent in low-resource settings and vulnerable populations, particularly during pregnancy and lactation and in children, due to the unavailability of advanced detection methods. An inexpensive point-of-care semi-quantitative method could support early detection of VAD in such conditions. This study used a gold nanoparticle (AuNP)- based lateral flow assay (LFA) to detect VAD, with retinol-binding protein (RBP) as a Marker. The Nanoparticle Tracking Analysis and NanoDrop were used to characterize AuNPs conjugated with anti-RBP antibody and to determine the optimal conjugation pH, respectively. Antibody concentrations were optimized on nitrocellulose membranes to achieve reproducible, semi-quantitative visual signals. The values obtained from the LFA semiquantitative kit were confirmed and validated by ELISA, and the developed color chart was evaluated for sensitivity, specificity, and accuracy. Optimal conditions for antibody conjugation were achieved at pH 8.5, and 0.5–1 µg of the capture antibody resulted in the formation of the test line. The LFA demonstrated good agreement with ELISA in distinguishing low RBP from normal RBP levels, enabling classification into normal (> 19 µg/mL), subclinical (12–19 µg/mL), and clinical deficiency (< 12 µg/mL) categories, with 93.70% accuracy, 93.95% sensitivity, and 92.73% specificity. The presented semiquantitative LFA demonstrates promising results for a rapid, simple, economical, and point-of-care screening for VAD, suitable for limited-resource settings. While clinical verification is needed to validate the clinical cutoffs and the test’s feasibility for Point-of-care screening, this kit provides an opportunity to develop several semiquantitative kits for other biomarker proteins.

Scientific Reports
Manipal Academy of Higher Education (IN), Kasturba Medical College, Mangalore (IN), Kasturba Medical College, Manipal (IN)
Biosensors and Analytical Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon